Insights | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Blog | September 18, 2024

Should the Experimental Use Exception Be Broadened?

Article | September 16, 2024

Duty of Disclosure and Consistency Requirements for Statements to PTO and Other Government Agencies

Blog | September 05, 2024

The Final Word on an Alleged Infringer’s Intent in a Hatch-Waxman Safe Harbor Analysis

Blog | May 09, 2024

Federal Circuit Reiterates That an Alleged Infringer’s Intent Is Irrelevant in a Hatch-Waxman Safe Harbor Analysis

Blog | March 31, 2023

Federal Circuit to Consider the Relevance of an Alleged Infringer’s “Intent” in a Hatch-Waxman Safe Harbor Analysis

Article | March 31, 2022

Fish Attorneys Author IP Litigator Article, "Regenxbio v. Sarepta: Make Sure You're Safely Within the Safe Harbor Before Using a 'Research Tool'"

Blog | January 19, 2022

REGENXBIO v. SAREPTA: Make Sure You're Safely Within the Safe Harbor Before Using a "Research Tool"

Blog | June 04, 2021

Users of Research Tools Take Note

Blog | August 05, 2020

Attorneys for Branded Companies Should Carefully Review ANDAs for Admissions Regarding Generic Infringement

Webinar | July 21, 2020

Navigating to the Safe Harbor: What to Know in Advance

Webinar | July 07, 2020

Antitrust Implications of Biologic Patent Settlements

Blog | June 26, 2020

First Circuit Finds Device Patent Improperly Listed in the Orange Book